Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_assertion type Assertion NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_head.
- NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_assertion description "[RAR?, TMEFF2 and CYGB displayed no apparent methylation, while a combinatory epigenotype based on p16, hTERT, RASSF1 and WT1 was associated with a significantly higher chance of detecting malignancy in any positive sample (odds ratio: 24, 95% CI: 4.7-125, P<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_provenance.
- NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_assertion evidence source_evidence_literature NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_provenance.
- NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_assertion SIO_000772 21063414 NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_provenance.
- NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_assertion wasDerivedFrom befree-20150227 NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_provenance.
- NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_assertion wasGeneratedBy ECO_0000203 NP665983.RAmpE-0FdN-nGEJFs1pRn7WUffg9hUkHUN0MP98loaqus130_provenance.